Latest filing published 22 Feb 2023 for CRISPR Therapeutics AG.
Insider track record
No signal scores available.
Brendan Smith: trading record in brief
All filings by Brendan Smith on record concern CRISPR Therapeutics AG. The record holds 3 filings, for trades running from 14 October 2022 to 18 February 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 22 February 2023 with an option exercise in CRISPR Therapeutics AG. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brendan Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,825 sharesCommon SharesSEC:0001209191-23-011790:0
- 1,111 shares@ US$55.76100.0% of flowCommon SharesSEC:0001209191-22-053989:1
- 3,750 sharesCommon SharesSEC:0001209191-22-053989:0
3 of 3 declarations
